Professional statement
Dr Nora Ng is a consultant rheumatologist in London with extensive experience in diagnosing and managing inflammatory rheumatic conditions. Her clinical expertise includes early inflammatory arthritis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, as well as the use of advanced biological therapies. She also has particular expertise in the management of gout and osteoporosis.
Dr Ng graduated from the University of Nottingham in 2003 and completed her specialist rheumatology training at several leading London teaching hospitals, including Imperial College Healthcare NHS Trust, The Royal London Hospital, and University College Hospital. She is currently a consultant rheumatologist at Guy’s and St Thomas’ NHS Foundation Trust.
Alongside her NHS role, Dr Ng offers private consultations at HCA UK at The Shard, Chelsea Outpatient Centre, Princess Grace Hospital Outpatients and Fortius Clinic London, where she provides thorough assessments and personalised treatment plans tailored to each patient.
Dr Ng also has a strong academic interest in the use of musculoskeletal ultrasound in inflammatory arthritis, for which she completed an MD. She has presented her research at national and international conferences and is committed to delivering evidence-based, compassionate care to help patients achieve the best possible outcomes.
Clinics
HCA UK at The Shard
Central London, 32 St Thomas Street, SE1 9BS,Medical insurances accepted
Credentials
Professional experience
- 22 years of experience
- Consultant rheumatologist (NHS), Guy’s and St. Thomas’ Trust ( current )
Subspecialties
- Rheumatoid arthritis
- Inflammatory arthritis
Professional memberships
- Fellow of the Royal College of Physicians (FRCP)
- British Society of Rheumatology
Education
- MD (research degree)
- BMedSci
Publications and conferences
- Dr Ng's publications are available on ResearchGate|https://www.researchgate.net/scientific-contributions/Nora-Ng-2132583692
- Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial. Cope AP, Jasenecova M, Vasconcelos JC, Qureshi S, van Schie KA, Filer A, Raza K, D'Agostino MA, McInnes IB, Siebert S, Isaacs JD, Pratt AG, Fisher BA, Buckley CD, Emery P, Mankia K, Ho P, Buch MH, Ciurtin C, van Schaardenburg D, Huizinga TWJ, Toes REM, Georgiou E, Kelly J, Murphy C, Prevost AT; ALTO Study Investigators. Lancet Rheumatol. 2026 Jan 20:S2665-9913(25)00371-6. doi: 10.1016/S2665- 9913(25)00371-6.
Languages spoken
- English